Financials Apollo Hospitals Enterprise Limited

Equities

APOLLOHOSP

INE437A01024

Healthcare Facilities & Services

Market Closed - NSE India S.E. 07:43:53 2024-07-12 am EDT 5-day change 1st Jan Change
6,354 INR -0.55% Intraday chart for Apollo Hospitals Enterprise Limited +0.40% +11.39%

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 170,790 158,471 417,357 649,346 619,841 913,593 - -
Enterprise Value (EV) 1 201,137 185,849 442,681 660,331 636,264 929,451 938,269 927,932
P/E ratio 72.3 x 34.8 x 270 x 61.5 x 75.7 x 102 x 61.4 x 45.1 x
Yield 0.49% 0.53% 0.1% 0.26% 0.35% 0.25% 0.26% 0.34%
Capitalization / Revenue 1.78 x 1.41 x 3.95 x 4.43 x 3.73 x 4.8 x 4.1 x 3.51 x
EV / Revenue 2.09 x 1.65 x 4.19 x 4.5 x 3.83 x 4.88 x 4.21 x 3.56 x
EV / EBITDA 18.9 x 11.7 x 38.9 x 30.2 x 31.7 x 38.6 x 29.7 x 23.4 x
EV / FCF 89 x 23.9 x 45.3 x 68.9 x 256 x 119 x 84.2 x 54.7 x
FCF Yield 1.12% 4.19% 2.21% 1.45% 0.39% 0.84% 1.19% 1.83%
Price to Book 5.12 x 4.75 x 9.07 x 11.5 x 10 x 13.2 x 11.2 x 9.16 x
Nbr of stocks (in thousands) 139,125 139,125 143,785 143,785 143,785 143,785 - -
Reference price 2 1,228 1,139 2,903 4,516 4,311 6,354 6,354 6,354
Announcement Date 5/30/19 6/25/20 6/23/21 5/25/22 5/30/23 5/30/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 96,174 112,468 105,600 146,626 166,124 190,592 222,712 260,375
EBITDA 1 10,637 15,873 11,374 21,851 20,065 24,106 31,619 39,632
EBIT 1 6,681 9,676 5,643 15,844 13,912 17,236 24,479 31,760
Operating Margin 6.95% 8.6% 5.34% 10.81% 8.37% 9.04% 10.99% 12.2%
Earnings before Tax (EBT) 1 3,726 6,601 2,215 15,854 11,008 13,805 21,316 29,142
Net income 1 2,360 4,549 1,504 10,556 8,191 8,986 14,849 20,294
Net margin 2.45% 4.05% 1.42% 7.2% 4.93% 4.71% 6.67% 7.79%
EPS 2 16.97 32.70 10.74 73.42 56.97 62.50 103.5 141.0
Free Cash Flow 1 2,260 7,780 9,780 9,585 2,485 7,834 11,144 16,973
FCF margin 2.35% 6.92% 9.26% 6.54% 1.5% 4.11% 5% 6.52%
FCF Conversion (EBITDA) 21.25% 49.01% 85.98% 43.86% 12.39% 32.5% 35.24% 42.83%
FCF Conversion (Net income) 95.75% 171.01% 650.43% 90.8% 30.34% 87.18% 75.05% 83.63%
Dividend per Share 2 6.000 6.000 3.000 11.75 15.00 16.00 16.22 21.77
Announcement Date 5/30/19 6/25/20 6/23/21 5/25/22 5/30/23 5/30/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 27,598 28,680 37,602 37,171 36,389 35,464 37,956 42,511 42,636 43,022 44,178 48,163 48,265 49,411 53,335
EBITDA 1 3,903 4,118 5,199 6,150 5,870 4,632 4,907 5,654 5,054 4,917 5,090 6,129 6,147 6,398 6,884
EBIT 1 2,653 2,734 3,793 4,702 4,380 2,968 3,430 4,104 3,520 3,327 3,421 4,538 4,491 4,750 5,457
Operating Margin 9.61% 9.53% 10.09% 12.65% 12.04% 8.37% 9.04% 9.65% 8.26% 7.73% 7.74% 9.42% 9.31% 9.61% 10.23%
Earnings before Tax (EBT) 1 1,853 2,376 3,051 3,830 3,675 2,357 2,543 3,271 2,658 2,536 2,641 3,836 3,696 3,953 4,051
Net income 1 1,304 1,678 4,893 2,478 2,284 901.4 3,171 2,040 1,535 1,445 1,666 2,556 2,471 2,686 3,132
Net margin 4.73% 5.85% 13.01% 6.67% 6.28% 2.54% 8.35% 4.8% 3.6% 3.36% 3.77% 5.31% 5.12% 5.44% 5.87%
EPS 2 9.380 11.77 34.03 17.24 15.88 6.270 22.05 14.19 10.67 10.50 11.59 20.53 17.36 17.44 22.26
Dividend per Share 2 - 3.000 - - - 11.75 - - - 9.000 - - - 11.48 -
Announcement Date 2/12/21 6/23/21 8/13/21 11/12/21 2/11/22 5/25/22 8/11/22 11/10/22 2/14/23 5/30/23 8/11/23 - - - -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 30,347 27,379 25,325 10,985 16,423 15,441 24,676 14,339
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.853 x 1.725 x 2.227 x 0.5027 x 0.8185 x 0.6405 x 0.7804 x 0.3618 x
Free Cash Flow 1 2,260 7,780 9,780 9,585 2,485 7,834 11,144 16,973
ROE (net income / shareholders' equity) 7.17% 13.6% 3.79% 20.6% 13.9% 13.7% 19.1% 21.8%
ROA (Net income/ Total Assets) 2.65% 4.43% 1.32% 8.57% 5.91% 5.76% 8.94% 10.8%
Assets 1 88,978 102,607 113,780 123,155 138,485 155,904 166,008 187,891
Book Value Per Share 2 240.0 240.0 320.0 393.0 431.0 482.0 567.0 694.0
Cash Flow per Share 2 65.00 92.70 91.00 112.0 95.80 134.0 160.0 199.0
Capex 1 6,789 5,119 2,955 6,572 11,285 11,368 10,711 12,425
Capex / Sales 7.06% 4.55% 2.8% 4.48% 6.79% 5.96% 4.81% 4.77%
Announcement Date 5/30/19 6/25/20 6/23/21 5/25/22 5/30/23 5/30/24 - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
6,354 INR
Average target price
6,864 INR
Spread / Average Target
+8.03%
Consensus
  1. Stock Market
  2. Equities
  3. APOLLOHOSP Stock
  4. Financials Apollo Hospitals Enterprise Limited